ENRILONG Trademark

Trademark Overview


On Friday, February 24, 2023, a trademark application was filed for ENRILONG with the United States Patent and Trademark Office. The USPTO has given the ENRILONG trademark a serial number of 97811501. The federal status of this trademark filing is WITHDRAWN BEFORE ISSUE as of Friday, April 26, 2024. This trademark is owned by 3D Medicines (Beijing) Co., Ltd.. The ENRILONG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer; Medicinal preparations for the prevention and treatment of tumors; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Antiviral drugs for medical purposes; Crude drugs in the nature of pharmaceutical preparations for the treatment of immune system related diseases and disorders; Gelatin capsules sold empty for pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral related diseases and disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for tumors; Injectable pharmaceuticals for treatment of cancer; Biological preparations for the treatment of cancer
enrilong

General Information


Serial Number97811501
Word MarkENRILONG
Filing DateFriday, February 24, 2023
Status694 - WITHDRAWN BEFORE ISSUE
Status DateFriday, April 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized wording "Enrilong".
Goods and ServicesPharmaceutical products for the prevention and treatment of cancer; Medicinal preparations for the prevention and treatment of tumors; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Antiviral drugs for medical purposes; Crude drugs in the nature of pharmaceutical preparations for the treatment of immune system related diseases and disorders; Gelatin capsules sold empty for pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral related diseases and disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for tumors; Injectable pharmaceuticals for treatment of cancer; Biological preparations for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 16, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party Name3D Medicines (Beijing) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBeijing 100176
CN

Party Name3D Medicines (Beijing) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBeijing 100176
CN

Trademark Events


Event DateEvent Description
Tuesday, February 28, 2023NEW APPLICATION ENTERED
Thursday, March 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 24, 2023ASSIGNED TO EXAMINER
Saturday, November 25, 2023NON-FINAL ACTION WRITTEN
Saturday, November 25, 2023NON-FINAL ACTION E-MAILED
Saturday, November 25, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 8, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 10, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 19, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Thursday, February 1, 2024ELECTRONIC RECORD REVIEW COMPLETE
Thursday, June 27, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, June 27, 2024WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, April 26, 2024WITHDRAWN FROM ISSUE - COMM.OFFICE REQUEST